Invention Grant
- Patent Title: Use of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances
- Patent Title (中): 使用加兰他敏治疗中枢神经系统的病理表现，基于与精神药物的中毒
-
Application No.: US10475357Application Date: 2002-04-18
-
Publication No.: US08207159B2Publication Date: 2012-06-26
- Inventor: Klaus Opitz , Joachim Moormann , Thomas Hille , Frank Becher
- Applicant: Klaus Opitz , Joachim Moormann , Thomas Hille , Frank Becher
- Applicant Address: DE Werne
- Assignee: HF Arzneimittelforschung GmbH
- Current Assignee: HF Arzneimittelforschung GmbH
- Current Assignee Address: DE Werne
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: DE10119862 20010424
- International Application: PCT/EP02/04277 WO 20020418
- International Announcement: WO02/085370 WO 20021031
- Main IPC: A61K31/55
- IPC: A61K31/55
Abstract:
The invention relates to the use of galanthamine, as free base or as acid addition salt, for the treatment of cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders occurring through intake of psychotropic substances as a consequence of occasional or chronic abuse of addictive substances, intoxicants or medicines, or as side effects of the use, especially repeated or prolonged, as intended of medicaments, or as an effect of use, in particular repeated or prolonged, not as intended of medicaments, or as a result of acute poisoning by psychotropic toxic substances, or as a result of chronic exposure to toxic substances with a psychotropic effect in humans or other vertebrates.
Public/Granted literature
Information query
